• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国疟原虫种群中恶性疟原虫多药耐药 1 基因的遗传多样性。

Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.

机构信息

Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.

Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

出版信息

Infect Genet Evol. 2018 Oct;64:168-177. doi: 10.1016/j.meegid.2018.06.027. Epub 2018 Jun 21.

DOI:10.1016/j.meegid.2018.06.027
PMID:29936038
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6420305/
Abstract

Plasmodium vivax resistance to chloroquine (CQ) was first reported over 60 years ago. Here we analyzed sequence variations in the multidrug resistance 1 gene (Pvmdr1), a putative molecular marker for P. vivax CQ resistance, in field isolates collected from three sites in Thailand during 2013-2016. Several single nucleotide polymorphisms previously implicated in reduced CQ sensitivity were found. These genetic variations encode amino acids in the two nucleotide-binding domains as well as the transmembrane domains of the protein. The high level of genetic diversity of Pvmdr1 provides insights into the evolutionary history of this gene. Specifically, there was little evidence of positive selection at amino acid F1076L in global isolates to be promoted as a possible marker for CQ resistance. Population genetic analysis clearly divided the parasites into eastern and western populations, which is consistent with their geographical separation by the central malaria-free area of Thailand. With CQ-primaquine remaining as the frontline treatment for vivax malaria in all regions of Thailand, such a population subdivision could be shaped and affected by the current drugs for P. falciparum since mixed P. falciparum/P. vivax infections often occur in this region.

摘要

恶性疟原虫对氯喹(CQ)的耐药性早在 60 多年前就有报道。本研究分析了 2013-2016 年在泰国三个地点采集的现场分离株中多药耐药 1 基因(Pvmdr1)的序列变异,该基因被认为是恶性疟原虫对 CQ 耐药的一个潜在分子标志物。研究发现了先前与 CQ 敏感性降低相关的几个单核苷酸多态性。这些遗传变异编码了蛋白中两个核苷酸结合结构域和跨膜结构域的氨基酸。Pvmdr1 的高度遗传多样性为该基因的进化历史提供了线索。具体来说,在全球分离株中,F1076L 氨基酸的正选择证据很少,这表明其不太可能作为 CQ 耐药的一个可能标志物。种群遗传分析清楚地将寄生虫分为东部和西部种群,这与泰国中部无疟疾区的地理隔离相一致。由于 CQ-伯氨喹啉仍然是泰国所有地区间日疟的一线治疗药物,这种种群细分可能会受到当前治疗恶性疟原虫药物的影响,因为该地区经常出现混合感染恶性疟原虫和间日疟原虫的情况。

相似文献

1
Genetic diversity of the Plasmodium vivax multidrug resistance 1 gene in Thai parasite populations.泰国疟原虫种群中恶性疟原虫多药耐药 1 基因的遗传多样性。
Infect Genet Evol. 2018 Oct;64:168-177. doi: 10.1016/j.meegid.2018.06.027. Epub 2018 Jun 21.
2
Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination.大湄公河次区域消除疟疾期间恶性疟原虫多药耐药 1 基因的演变。
Parasit Vectors. 2020 Feb 12;13(1):67. doi: 10.1186/s13071-020-3934-5.
3
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.马达加斯加间日疟原虫对氯喹的耐药性:pvmdr1和pvcrt - o基因的临床疗效及多态性
Antimicrob Agents Chemother. 2008 Dec;52(12):4233-40. doi: 10.1128/AAC.00578-08. Epub 2008 Sep 22.
4
The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.2008 年和 2014 年泰国边境地区间日疟原虫的耐药分子标志物流行情况。
Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):229-237. doi: 10.1016/j.ijpddr.2018.04.003. Epub 2018 Apr 12.
5
Drug resistance markers in Plasmodium vivax isolates from a Kanchanaburi province, Thailand between January to May 2023.2023 年 1 月至 5 月期间在泰国北碧府的间日疟原虫分离株中发现的耐药性标记物。
PLoS One. 2024 Jul 5;19(7):e0304337. doi: 10.1371/journal.pone.0304337. eCollection 2024.
6
Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.间日疟原虫耐药基因;泰国疟疾流行地区与氯喹敏感性相关的Pvmdr1和Pvcrt-o基因多态性
Korean J Parasitol. 2015 Feb;53(1):43-9. doi: 10.3347/kjp.2015.53.1.43. Epub 2015 Feb 27.
7
Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes.中缅边境地区间日疟原虫分离株的体外药敏试验及与 Pvmdr1 和 Pvcrt-o 基因多态性的关系。
PLoS Negl Trop Dis. 2020 Jun 12;14(6):e0008255. doi: 10.1371/journal.pntd.0008255. eCollection 2020 Jun.
8
Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India.氯喹疗效研究证实了印度钦奈间日疟原虫对该药物的敏感性。
Malar J. 2014 Mar 31;13:129. doi: 10.1186/1475-2875-13-129.
9
Characterization of Polymorphisms in Isolates from Mangaluru, India.印度芒格洛尔分离株的多态性特征。
Am J Trop Med Hyg. 2019 Aug;101(2):416-417. doi: 10.4269/ajtmh.19-0224.
10
Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries.pvmdr1 和 pvcrt-o 基因的遗传多态性与来自疟疾流行国家的间日疟原虫分离株的体外药物敏感性有关。
Acta Trop. 2011 Feb;117(2):69-75. doi: 10.1016/j.actatropica.2010.08.011. Epub 2010 Oct 8.

引用本文的文献

1
Molecular epidemiology and genetic diversity of disappearing Plasmodium vivax in southern Thailand.泰国南部间日疟原虫消失的分子流行病学与遗传多样性
Sci Rep. 2025 Jan 21;15(1):2620. doi: 10.1038/s41598-025-86578-8.
2
Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand.泰国西北部间日疟原虫 Duffy 结合蛋白和裂殖子表面蛋白-1 的遗传多样性和分子进化。
Infect Genet Evol. 2023 Sep;113:105467. doi: 10.1016/j.meegid.2023.105467. Epub 2023 Jun 15.
3
Characteristics of molecular markers associated with chloroquine resistance in Plasmodium vivax strains from vivax malaria cases in Yunnan Province, China.中国云南省间日疟病例中与氯喹耐药相关的疟原虫株的分子标记特征。
Malar J. 2023 Jun 11;22(1):181. doi: 10.1186/s12936-023-04616-0.
4
The activity of methylene blue against asexual and sexual stages of .亚甲蓝对无性和有性阶段的 的活性。
Front Cell Infect Microbiol. 2023 Apr 18;13:1108366. doi: 10.3389/fcimb.2023.1108366. eCollection 2023.
5
Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.大湄公河次区域持续性疟疾传播的多学科研究。
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):138-151. doi: 10.4269/ajtmh.21-1267.
6
Single-cell genome sequencing of protozoan parasites.原生动物寄生虫的单细胞基因组测序。
Trends Parasitol. 2021 Sep;37(9):803-814. doi: 10.1016/j.pt.2021.05.013. Epub 2021 Jun 22.
7
Molecular surveillance of the Plasmodium vivax multidrug resistance 1 gene in Peru between 2006 and 2015.2006 年至 2015 年间秘鲁恶性疟原虫多药耐药 1 号基因的分子监测。
Malar J. 2020 Dec 4;19(1):450. doi: 10.1186/s12936-020-03519-8.
8
Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar.对来自泰国和缅甸的间日疟原虫同源 crt 和 mdr1 基因的遗传分析。
Malar J. 2020 Aug 31;19(1):315. doi: 10.1186/s12936-020-03391-6.
9
Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination.大湄公河次区域消除疟疾期间恶性疟原虫多药耐药 1 基因的演变。
Parasit Vectors. 2020 Feb 12;13(1):67. doi: 10.1186/s13071-020-3934-5.

本文引用的文献

1
Substantial population structure of Plasmodium vivax in Thailand facilitates identification of the sources of residual transmission.泰国间日疟原虫显著的种群结构有助于确定残余传播的来源。
PLoS Negl Trop Dis. 2017 Oct 16;11(10):e0005930. doi: 10.1371/journal.pntd.0005930. eCollection 2017 Oct.
2
Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.氯喹对缅甸高基因多样性和中等寄生虫基因流动人群中间日疟原虫的疗效。
Malar J. 2017 Jul 10;16(1):281. doi: 10.1186/s12936-017-1912-y.
3
Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1.伊朗间日疟原虫的分子流行病学:使用中性标记显示高度多样性和复杂亚结构,但无证据表明pvmdr1存在Y976F突变。
PLoS One. 2016 Nov 9;11(11):e0166124. doi: 10.1371/journal.pone.0166124. eCollection 2016.
4
Genomic analysis of local variation and recent evolution in Plasmodium vivax.间日疟原虫局部变异和近期进化的基因组分析。
Nat Genet. 2016 Aug;48(8):959-964. doi: 10.1038/ng.3599. Epub 2016 Jun 27.
5
Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax.群体基因组学研究确定了间日疟原虫全球传播和耐药性的特征。
Nat Genet. 2016 Aug;48(8):953-8. doi: 10.1038/ng.3588. Epub 2016 Jun 27.
6
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.恶性疟原虫K13螺旋桨多态性的全球地图。
N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.
7
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.全球普遍存在的 PfMDR1 突变可调节恶性疟原虫对基于青蒿素的联合疗法的敏感性。
Nat Commun. 2016 May 18;7:11553. doi: 10.1038/ncomms11553.
8
MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets.MEGA7:适用于更大数据集的分子进化遗传学分析版本7.0
Mol Biol Evol. 2016 Jul;33(7):1870-4. doi: 10.1093/molbev/msw054. Epub 2016 Mar 22.
9
Natural human Plasmodium infections in major Anopheles mosquitoes in western Thailand.泰国西部主要按蚊体内的人类自然疟原虫感染情况。
Parasit Vectors. 2016 Jan 13;9:17. doi: 10.1186/s13071-016-1295-x.
10
Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivax.间日疟原虫中mdr1基因的多个突变起源——氯喹抗性的一个假定标志物
PLoS Negl Trop Dis. 2015 Nov 5;9(11):e0004196. doi: 10.1371/journal.pntd.0004196. eCollection 2015 Nov.